Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mechanisms of Resistance

Biochemical Analysis of Metallo-β-Lactamase NDM-3 from a Multidrug-Resistant Escherichia coli Strain Isolated in Japan

Tatsuya Tada, Tohru Miyoshi-Akiyama, Kayo Shimada, Teruo Kirikae
Tatsuya Tada
Department of Infectious Diseases, Research Institute, National Center for Global Health and Medicine, Toyama, Shinjuku, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tohru Miyoshi-Akiyama
Department of Infectious Diseases, Research Institute, National Center for Global Health and Medicine, Toyama, Shinjuku, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kayo Shimada
Department of Infectious Diseases, Research Institute, National Center for Global Health and Medicine, Toyama, Shinjuku, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Teruo Kirikae
Department of Infectious Diseases, Research Institute, National Center for Global Health and Medicine, Toyama, Shinjuku, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.02793-13
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

New Delhi metallo-β-lactamase-3 (NDM-3) was identified in a multidrug-resistant Escherichia coli isolate, NCGM77, obtained from the feces of a patient in Japan. The enzymatic activities of NDM-3 against β-lactams were similar to those of NDM-1, although NDM-3 showed slightly lower kcat/Km ratios for all the β-lactams tested except for doripenem. The genetic context for blaNDM-3 was tnpA-blaNDM-3-bleMBL-trpF-dsbC-tnpA-sulI-qacEdeltaI-aadA2-dfrA1, which was present on an approximately 250-kb plasmid.

TEXT

Metallo-β-lactamases (MBLs) are produced by many species of Gram-negative bacteria and some species of Gram-positive bacteria, including Bacillus spp. (1, 2). MBLs can confer resistance or reduced susceptibility to carbapenems and, usually, to cephalosporins and to penicillins except for monobactams (3). New Delhi metallo-β-lactamase-1 (NDM-1), a recently discovered MBL, was initially found in Sweden from Klebsiella pneumoniae and Escherichia coli isolates that originated from India (4). Subsequently, at least 10 NDM variants (see www.lahey.org/studies) have been reported in several different countries (5–17).

Escherichia coli NCGM77 was isolated from the feces of a patient in a medical setting in Japan in 2013. The isolate was phenotypically identified, and species identification was confirmed by 16S rRNA sequencing (18). MICs were determined using the broth microdilution method as recommended by the Clinical and Laboratory Standards Institute (19). E. coli NCGM77 was resistant to various tested β-lactams (Table 1); the MICs of the other antibiotics were 32 μg/ml (amikacin), 8 μg/ml (arbekacin), 256 μg/ml (ciprofloxacin), <0.25 μg/ml (colistin), >1,024 μg/ml (fosfomycin), 64 μg/ml (gentamicin), 512 μg/ml (kanamycin), 32 μg/ml (levofloxacin), 1 μg/ml (minocycline), <0.25 μg/ml (tigecycline), and 64 μg/ml (tobramycin). PCR analysis for MBL genes of blaDIM, blaGIM, blaIMP, blaNDM, blaSIM, blaSPM, and blaVIM was performed (20, 21). On the basis of the PCR results, the isolate was positive for blaNDM. The DNA sequence of the PCR product revealed that the isolate had the blaNDM-3 gene (9). Multilocus sequence typing (MLST) of NCGM77 found it to be sequence type 88 (ST88) (E. coli MLST database [see http://www.pasteur.fr/recherche/genopole/PF8/mlst/EColi.html]). Pseudomonas aeruginosa IOMTU9 (17) was used as a source of the blaNDM-1 gene.

View this table:
  • View inline
  • View popup
TABLE 1

MICs of various β-lactams for E. coli strains NCGM77 and DH5α transformed with plasmids carrying NDM-1 or NDM-3

The blaNDM-3 and blaNDM-1 genes were cloned into the corresponding sites of pHSG398 (TaKaRa, Shiga, Japan) using the primer set EcoRI-NDM-F (5′-GGGAATTCATGGAATTGCCCAATATTATG-3′) and PstI-NDM-R (5′-AACTGCAGTCAGCGCAGCTTGTCGGCCAT-3′). The Escherichia coli DH5α strain was transformed with pHSG398-NDM-3 or pHSG398-NDM-1 to determine the MICs of β-lactams.

The open reading frames of NDM-1 and NDM-3 without signal peptide regions were cloned into the pET28a expression vector (Novagen, Inc., Madison, WI) using the primer set BamHI-TEV-NDM-F (5′-ATGGATCCGAAAACCTGTATTTCCAAGGCCAGCAAATGGAAACTGGCGAC-3′) and XhoI-NDM-R (5′-ATCTCGAGTCAGCGCAGCTTGTCGGCCATG-3′). Plasmids were transformed into E. coli BL21-CodonPlus (DE3)-RIP (Agilent Technologies, Santa Clara, CA). Recombinant NDM proteins were purified using nickel-nitrilotriacetic acid (Ni-NTA) agarose according to the manufacturer's instructions (Qiagen, Hilden, Germany). His tags were removed by digestion with TurboTEV protease (Accelagen, San Diego, CA), and untagged proteins were purified by an additional passage over the Ni-NTA agarose. The purities of NDM-1 and NDM-3 were >90%, as estimated by SDS-PAGE. During the purification procedure, the presence of β-lactamase activity was monitored using nitrocefin (Oxoid Ltd., Basingstoke, United Kingdom). Initial hydrolysis rates were determined in 50 mM phosphate buffer (pH 7.0) containing 5 μM Zn(NO3)2 at 37°C, using a UV-visible spectrophotometer (V-530; Jasco, Tokyo, Japan). The Km and kcat values and the kcat/Km ratios were determined by analyzing β-lactam hydrolysis using a Lineweaver-Burk plot. Wavelengths and extinction coefficients for β-lactam substrates have been reported previously (22–24). Three individual experiments were performed to determine the Km and kcat values.

All cloned genes in the pHSG398 and pQE2 vectors were sequenced using an ABI PRISM 3130 sequencer (Applied Biosystems, Foster City, CA).

The plasmid harboring blaNDM-3 was extracted (25) and sequenced by MiSeq (Illumina, San Diego, CA). The size of the plasmid harboring blaNDM-3 was determined using pulsed-field gel electrophoresis (PFGE) and Southern hybridization (12). A probe for blaNDM-3 was amplified by PCR by using the EcoRI-NDM-F and the PstI-NDM-R primers. Signal detection was carried out using the DIG High Prime DNA labeling and detection starter kit II (Roche Applied Science, Indianapolis, IN).

The blaNDM-3 probe hybridized to a 250-kb plasmid (Fig. 1). The sequence surrounding blaNDM-3 was tnpA-blaNDM-3-bleMBL-trpF-dsbC-tnpA-sulI-qacEdeltaI-aadA2-dfrA1. This plasmid showed more than 99.9% identity at the nucleotide sequence level from 69,229 to 78,275 bp of the pGUE plasmid (GenBank accession no. JQ364967) from the E. coli strain GUE, which was isolated in India (26). The entire sequence of the plasmid was not determined with the sequence data generated by MiSeq (Illumina).

FIG 1
  • Open in new tab
  • Download powerpoint
FIG 1

Localization of the blaNDM-3 gene on the plasmid of E. coli strain NCGM77 separated by PFGE. Lane M, midrange PFG marker (New England BioLabs, Tokyo, Japan); lane A, plasmids of E. coli strain NCGM77; lane B, hybridization of the plasmid with a probe specific for the blaNDM-3 gene.

Expression of the blaNDM-3 and blaNDM-1 genes in E. coli DH5α conferred resistance or reduced susceptibility to all cephalosporins, moxalactam, and carbapenems (Table 1). The MIC of cefpirome was 2-fold higher for E. coli expressing NDM-3 than for E. coli expressing NDM-1. In contrast, those of cefepime, cefoselis, cefotaxime, cefoxitin, imipenem, meropenem, and penicillin G were 2-fold lower for NDM-3 than for NDM-1.

As shown in Table 2, recombinant NDM-3 and NDM-1 hydrolyzed all β-lactams tested except for aztreonam. The profiles of the enzymatic activities of NDM-3 against β-lactams tested were similar to those of NDM-1, although NDM-3 had slightly but significantly lower kcat/Km ratios for all β-lactams tested except for doripenem. The lower kcat/Km ratios were mostly caused by the lower kcat values of NDM-3 compared with those of NDM-1, i.e., the values of NDM-3 were 19.0 to 47.5% of those of NDM-1 (Table 2). In fact, the substitution from Asp to Asn at position 95 of NDM appeared to decrease the hydrolysis rate of all β-lactams tested except for doripenem (Table 2). An amino acid substitution at position 95 from Asp to Asn decreased the kcat values of NDM-3 compared to those of NDM-1 (Table 2). Residue 95 is in α1, which is located on the protein surface. The crystal structure of NDM-1 revealed that the active site of NDM-1 is located at the bottom of a shallow groove enclosed by 2 important loops, L3 and L10 (27–30). Residue 95 in α1, however, was not located in these loops. This residue may indirectly affect the interaction of the substrate with the active site. Among all 9 NDM variants, amino acid substitutions were identified at 7 positions (28, 88, 95, 130, 152, 154, and 233). It remains unclear which position(s) plays a critical role in the enzymatic activities. Relative to IMP-1 and VIM-2, NDM-1 does not bind to carbapenems as tightly, but it turns over carbapenems at a rate similar to that of VIM-2 (4). NDM-4 with an amino acid substitution at position 154 (Met to Leu) showed greater hydrolytic activity toward carbapenems, cephalotin, cefotaxime, and ceftazidime than that shown by NDM-1 (12). NDM-5 with substitutions at positions 88 (Val to Leu) and 154 (Met to Leu) resulted in reduced susceptibilities of E. coli transformants to cephalosporins and carbapenems (12). NDM-8 with substitutions at positions 130 (Asp to Gly) and 154 (Met to Leu) resulted in enzymatic activities against β-lactams that were similar to those of NDM-1 (17). The drug susceptibilities of E. coli transformants with blaNDM-2, blaNDM-3, blaNDM-6, blaNDM-7, and blaNDM-9 have not been reported.

View this table:
  • View inline
  • View popup
TABLE 2

Kinetic parameters of NDM-3 and NDM-1 enzymesa

This is the first report describing NDM-3-producing Gram-negative pathogens in Japan. It appears that NDMs have recently begun evolving; therefore, careful monitoring of NDM-producing pathogens is required.

Plasmid sequence accession number.The plasmid sequence including the blaNDM-3 gene has been deposited in GenBank under the accession number AB898038.

ACKNOWLEDGMENTS

This study was supported by International Health Cooperation Research (grant 23-A-301), the Ministry of Health, Labor and Welfare of Japan (grant H24-Shinko-Ippan-010), and the JSPS KAKENHI (grant 24790432).

FOOTNOTES

    • Received 25 December 2013.
    • Returned for modification 27 January 2014.
    • Accepted 23 March 2014.
    • Accepted manuscript posted online 31 March 2014.
  • Copyright © 2014, American Society for Microbiology. All Rights Reserved.

REFERENCES

  1. 1.↵
    1. Queenan AM,
    2. Bush K
    . 2007. Carbapenemases: the versatile beta-lactamases. Clin. Microbiol. Rev. 20:440–458. doi:10.1128/CMR.00001-07.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Schlesinger SR,
    2. Kim SG,
    3. Lee JS,
    4. Kim SK
    . 2011. Purification development and characterization of the zinc-dependent metallo-beta-lactamase from Bacillus anthracis. Biotechnol. Lett. 33:1417–1422. doi:10.1007/s10529-011-0569-9.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Bush K
    . 2001. New beta-lactamases in Gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin. Infect. Dis. 32:1085–1089. doi:10.1086/319610.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Yong D,
    2. Toleman MA,
    3. Giske CG,
    4. Cho HS,
    5. Sundman K,
    6. Lee K,
    7. Walsh TR
    . 2009. Characterization of a new metallo-beta-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother. 53:5046–5054. doi:10.1128/AAC.00774-09.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Cornaglia G,
    2. Giamarellou H,
    3. Rossolini GM
    . 2011. Metallo-beta-lactamases: a last frontier for beta-lactams? Lancet Infect. Dis. 11:381–393. doi:10.1016/S1473-3099(11)70056-1.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Pillai DR,
    2. McGeer A,
    3. Low DE
    . 2011. New Delhi metallo-beta-lactamase-1 in Enterobacteriaceae: emerging resistance. CMAJ 183:59–64. doi:10.1503/cmaj.101487.
    OpenUrlFREE Full Text
  7. 7.↵
    1. Kaase M,
    2. Nordmann P,
    3. Wichelhaus TA,
    4. Gatermann SG,
    5. Bonnin RA,
    6. Poirel L
    . 2011. NDM-2 carbapenemase in Acinetobacter baumannii from Egypt. J. Antimicrob. Chemother. 66:1260–1262. doi:10.1093/jac/dkr135.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Espinal P,
    2. Fugazza G,
    3. Lopez Y,
    4. Kasma M,
    5. Lerman Y,
    6. Malhotra-Kumar S,
    7. Goossens H,
    8. Carmeli Y,
    9. Vila J
    . 2011. Dissemination of an NDM-2-producing Acinetobacter baumannii clone in an Israeli rehabilitation center. Antimicrob. Agents Chemother. 55:5396–5398. doi:10.1128/AAC.00679-11.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Poirel L,
    2. Bonnin RA,
    3. Boulanger A,
    4. Schrenzel J,
    5. Kaase M,
    6. Nordmann P
    . 2012. Tn125-related acquisition of blaNDM-like genes in Acinetobacter baumannii. Antimicrob. Agents Chemother. 56:1087–1089. doi:10.1128/AAC.05620-11.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Ghazawi A,
    2. Sonnevend A,
    3. Bonnin RA,
    4. Poirel L,
    5. Nordmann P,
    6. Hashmey R,
    7. Rizvi TA,
    8. Hamadeh MB,
    9. Pal T
    . 2012. NDM-2 carbapenemase-producing Acinetobacter baumannii in the United Arab Emirates. Clin. Microbiol. Infect. 18:E34–E36. doi:10.1111/j.1469-0691.2011.03726.x.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Rogers BA,
    2. Sidjabat HE,
    3. Silvey A,
    4. Anderson TL,
    5. Perera S,
    6. Li J,
    7. Paterson DL
    . 2013. Treatment options for New Delhi metallo-beta-lactamase-harboring Enterobacteriaceae. Microb. Drug Resist. 19:100–103. doi:10.1089/mdr.2012.0063.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Nordmann P,
    2. Boulanger AE,
    3. Poirel L
    . 2012. NDM-4 metallo-beta-lactamase with increased carbapenemase activity from Escherichia coli. Antimicrob. Agents Chemother. 56:2184–2186. doi:10.1128/AAC.05961-11.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Hornsey M,
    2. Phee L,
    3. Wareham DW
    . 2011. A novel variant, NDM-5, of the New Delhi metallo-beta-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom. Antimicrob. Agents Chemother. 55:5952–5954. doi:10.1128/AAC.05108-11.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Williamson DA,
    2. Sidjabat HE,
    3. Freeman JT,
    4. Roberts SA,
    5. Silvey A,
    6. Woodhouse R,
    7. Mowat E,
    8. Dyet K,
    9. Paterson DL,
    10. Blackmore T,
    11. Burns A,
    12. Heffernan H
    . 2012. Identification and molecular characterisation of New Delhi metallo-beta-lactamase-1 (NDM-1)- and NDM-6-producing Enterobacteriaceae from New Zealand hospitals. Int. J. Antimicrob. Agents 39:529–533. doi:10.1016/j.ijantimicag.2012.02.017.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Cuzon G,
    2. Bonnin RA,
    3. Nordmann P
    . 2013. First identification of novel NDM carbapenemase, NDM-7, in Escherichia coli in France. PLoS One. 8:e61322. doi:10.1371/journal.pone.0061322.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Gottig S,
    2. Hamprecht AG,
    3. Christ S,
    4. Kempf VA,
    5. Wichelhaus TA
    . 2013. Detection of NDM-7 in Germany, a new variant of the New Delhi metallo-beta-lactamase with increased carbapenemase activity. J. Antimicrob. Chemother. 68:1737–1740. doi:10.1093/jac/dkt088.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Tada T,
    2. Miyoshi-Akiyama T,
    3. Dahal RK,
    4. Sah MK,
    5. Ohara H,
    6. Kirikae T,
    7. Pokhrel BM
    . 2013. NDM-8 metallo-beta-lactamase in a multidrug-resistant Escherichia coli strain isolated in Nepal. Antimicrob. Agents Chemother. 57:2394–2396. doi:10.1128/AAC.02553-12.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Suzuki MT,
    2. Taylor LT,
    3. DeLong EF
    . 2000. Quantitative analysis of small-subunit rRNA genes in mixed microbial populations via 5′-nuclease assays. Appl. Environ. Microbiol. 66:4605–4614. doi:10.1128/AEM.66.11.4605-4614.2000.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    Clinical and Laboratory Standards Institute. 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 9th ed. Approved standard M07-A9. Clinical and Laboratory Standards Institute, Wayne, PA.
  20. 20.↵
    1. Ellington MJ,
    2. Kistler J,
    3. Livermore DM,
    4. Woodford N
    . 2007. Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. J. Antimicrob. Chemother. 59:321–322. doi:10.1093/jac/dkl481.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    1. Poirel L,
    2. Walsh TR,
    3. Cuvillier V,
    4. Nordmann P
    . 2011. Multiplex PCR for detection of acquired carbapenemase genes. Diagn. Microbiol. Infect. Dis. 70:119–123. doi:10.1016/j.diagmicrobio.2010.12.002.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Boschi L,
    2. Mercuri PS,
    3. Riccio ML,
    4. Amicosante G,
    5. Galleni M,
    6. Frere JM,
    7. Rossolini GM
    . 2000. The Legionella (Fluoribacter) gormanii metallo-beta-lactamase: a new member of the highly divergent lineage of molecular-subclass B3 beta-lactamases. Antimicrob. Agents Chemother. 44:1538–1543. doi:10.1128/AAC.44.6.1538-1543.2000.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Crowder MW,
    2. Walsh TR,
    3. Banovic L,
    4. Pettit M,
    5. Spencer J
    . 1998. Overexpression, purification, and characterization of the cloned metallo-beta-lactamase L1 from Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 42:921–926.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Queenan AM,
    2. Shang W,
    3. Flamm R,
    4. Bush K
    . 2010. Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem. Antimicrob. Agents Chemother. 54:565–569. doi:10.1128/AAC.01004-09.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Tarczynski MC,
    2. Meyer WJ,
    3. Min JJ,
    4. Wood KA,
    5. Hellwig RJ
    . 1994. Two-minute miniprep method for plasmid DNA isolation. Biotechniques 16:514–519.
    OpenUrlPubMed
  26. 26.↵
    1. Bonnin RA,
    2. Poirel L,
    3. Carattoli A,
    4. Nordmann P
    . 2012. Characterization of an IncFII plasmid encoding NDM-1 from Escherichia coli ST131. PLoS One 7:e34752. doi:10.1371/journal.pone.0034752.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Green VL,
    2. Verma A,
    3. Owens RJ,
    4. Phillips SE,
    5. Carr SB
    . 2011. Structure of New Delhi metallo-beta-lactamase 1 (NDM-1). Acta Crystallogr. F Struct. Biol. Cryst. Commun. 67:1160–1164. doi:10.1107/S1744309111029654.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Kim Y,
    2. Tesar C,
    3. Mire J,
    4. Jedrzejczak R,
    5. Binkowski A,
    6. Babnigg G,
    7. Sacchettini J,
    8. Joachimiak A
    . 2011. Structure of apo- and monometalated forms of NDM-1—a highly potent carbapenem-hydrolyzing metallo-beta-lactamase. PLoS One 6:e24621. doi:10.1371/journal.pone.0024621.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. King D,
    2. Strynadka N
    . 2011. Crystal structure of New Delhi metallo-beta-lactamase reveals molecular basis for antibiotic resistance. Protein Sci. 20:1484–1491. doi:10.1002/pro.697.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Zhang H,
    2. Hao Q
    . 2011. Crystal structure of NDM-1 reveals a common beta-lactam hydrolysis mechanism. FASEB J. 25:2574–2582. doi:10.1096/fj.11-184036.
    OpenUrlCrossRefPubMed
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Biochemical Analysis of Metallo-β-Lactamase NDM-3 from a Multidrug-Resistant Escherichia coli Strain Isolated in Japan
Tatsuya Tada, Tohru Miyoshi-Akiyama, Kayo Shimada, Teruo Kirikae
Antimicrobial Agents and Chemotherapy May 2014, 58 (6) 3538-3540; DOI: 10.1128/AAC.02793-13

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Biochemical Analysis of Metallo-β-Lactamase NDM-3 from a Multidrug-Resistant Escherichia coli Strain Isolated in Japan
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Biochemical Analysis of Metallo-β-Lactamase NDM-3 from a Multidrug-Resistant Escherichia coli Strain Isolated in Japan
Tatsuya Tada, Tohru Miyoshi-Akiyama, Kayo Shimada, Teruo Kirikae
Antimicrobial Agents and Chemotherapy May 2014, 58 (6) 3538-3540; DOI: 10.1128/AAC.02793-13
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • TEXT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596